πŸ‡ΊπŸ‡Έ FDA
Patent

US 10259824

Complement C3d-binding compounds

granted A61KA61K31/165A61P

Quick answer

US patent 10259824 (Complement C3d-binding compounds) held by The Regents of the University of California expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/165, A61P, A61P27/02